Genomics & A*STAR GIS launch TISHUMAP study to advance AI-driven drug target discovery: Pleasanton, California Monday, July 21, 2025, 13:00 Hrs [IST] 10x Genomics, Inc., a lea ...

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint: Pittsburgh Monday, July 21, 2025, 11:00 Hrs [IST] Viatris Inc., a global healthcare c ...

The Central Drugs Standard Control Organisation (CDSCO) has declared 185 drug samples tested by the Central and State drugs regulatory authorities in the month of June as Not of Standard Quality (NSQ) ...

Degrees Pharma & Tulane University ink research agreement to study tafenoquine against Lyme and Bartonella bacteria: Washington Monday, July 21, 2025, 09:00 Hrs [IST] 60 Degree ...

FPME’s “Export Pe Charcha” highlights merchant exporters’ role in making drugs globally accessible: Shardul Nautiyal, Mumbai ...

CDSCO issues SEC guidance document elaborating application, recommendation processes: Gireesh Babu, New Delhi Monday, July 21 ...

ICMR to hold workshop on clinical trials from Sept 15- 19 in Pune to empower ethical excellence in clinical research: Shardul Nautiyal, Mumbai Monday, July 21, 2025, 08:00 Hrs [IS ...

Microbial contamination limits in Schedule M to be amended to match with WHO standards: Gireesh Babu, New Delhi Monday, July 21, 2025, 08:00 Hrs [IST] The drug regulators are work ...

Indian pharma’s strength lies in its vigilant regulatory backbone: Harish K Jain: Nandita Vijayasimha, Bengaluru Monday, July 21, 2025, 08:00 Hrs [IST] India is recognized for i ...

Prima Mente launches Pleiades, a human epigenome foundation model with applications for Alzheimer’s disease: London Saturday, July 19, 2025, 18:00 Hrs [IST] San Francisco and Lo ...

Repare Therapeutics signs exclusive global licensing agreement with Debiopharm International for lunresertib: Cambridge, Massachusetts Saturday, July 19, 2025, 17:00 Hrs [IST] Rep ...